Clinical trial · Observational
Identification of Prognostic Gene Mutations in Biliary Tract Cancer Using Whole Genome Sequencing
NCT03718897CI-TRIAL-00035454unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to investigate genetic mutations affecting prognosis using whole genome sequencing in patients with biliary tract cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Biliary Tract Cancer | Malignant Biliary Tract Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Endoscopic retrograde cholangiopancreatogram | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Overall survival rate
- timeFrame
- 48 months
- description
- Comparisons of overall survival rates between patients with gene mutations and without.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients diagnosed with biliary tract cancer via endoscopic retrograde cholangiopancreatogram Exclusion Criteria: * Pregnancy * Other active tumors within 5 years * Coagulopathy * Severe mental illness
References
Publications (0)
Data not yet available
No reference posted for this study.